Krensavage Asset Management, LLC

Position in BNTX — BioNTech SE

CIK 1609251 NEW YORK, NY

Position in BNTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,290,404

-$4,184,185 QoQ

Shares Held

59,523

-40.2% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

2.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Krensavage Asset Management, LLC holds $143,120,529 across 9 Biotechnology names. BNTX ranks #7 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ENTA	Enanta Pharmaceuticals Inc	2,866,138	$36,199,322
2	JAZZ	Jazz Pharmaceuticals plc	167,816	$31,725,614
3	BMRN	Biomarin Pharmaceutical Inc	524,786	$29,645,161
4	EXEL	Exelixis, Inc.	415,693	$17,829,072
5	RARE	Ultragenyx Pharmaceutical Inc.	390,879	$8,188,915
6	VNDA	Vanda Pharmaceuticals Inc.	1,180,388	$8,156,481
7	BNTX	BioNTech SE This page	59,523	$5,290,404
8	REGN	Regeneron Pharmaceuticals, Inc.	4,000	$3,090,560

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,290,404	59,523	-40.2%	Shares	Sole	2026-05-15
2025-12-31	$9,474,589	99,523	+25.4%	Shares	Sole	2026-02-18
2025-09-30	$7,827,074	79,366	+8.2%	Shares	Sole	2025-11-17
2025-06-30	$7,812,981	73,382	-16.2%	Shares	Sole	2025-08-15
2025-03-31	$7,973,486	87,563	-1.2%	Shares	Sole	2025-05-15
2024-12-31	$10,103,148	88,663	-5.3%	Shares	Sole	2025-02-18
2024-09-30	$11,114,852	93,583	-29.3%	Shares	Sole	2024-11-15
2024-06-30	$10,631,065	132,293	+10.2%	Shares	Sole	2024-08-15
2024-03-31	$11,070,000	120,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.